Only two years after its inception, privately held Sunesis Pharmaceuticals Inc. raised $60 million in a private placement of preferred stock. The company, which is focused on the discovery of small-molecule drugs, completed the financing with several new arid …
Комментариев нет:
Отправить комментарий